Camilla M. Day

Clinical Psychology · 2016–2017

A researcher in the Science corpus: 3 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom Camilla M. Day trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Roland R. Griffiths
  2. Robin L. Carhart-Harris
  3. Matthew W. Johnson
  4. Katherine A. MacLean

Who trusts Camilla M. Day overall

  1. Robin L. Carhart-Harris

Papers from Camilla M. Day's perspective

Ordered by how strongly the researchers Camilla M. Day trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin (Proceedings of the National Academy of Sciences of the United States of America)
  2. Human Hallucinogen Research: Guidelines for Safety (Journal of Psychopharmacology)
  3. Psychedelics (Pharmacological Reviews)
  4. Pilot Study of the 5-HT2AR Agonist Psilocybin in the Treatment of Tobacco Addiction (Journal of Psychopharmacology)
  5. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. (Lancet psychiatry)
  6. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. (Journal of Clinical Psychiatry)
  7. Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (Journal of Psychopharmacology)
  8. Serotonin and brain function: a tale of two receptors (Journal of Psychopharmacology)
  9. The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future (Neuropsychopharmacology)
  10. Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression

Their papers